| Monday, November 5, 2007 |
| 08:00:00 |
Registration and Morning Coffee (08:00-09:00) |
|
| 09:00:00 |
Chairman’s Welcome and The ASAP/CHI Alliance (09:00-09:15) |
Mike Leonetti
|
| 09:15:00 |
Building Senior Management Leadership, Commitment and Access – Presentation and Discussion (09:15-10:00) |
John Buckingham
|
| 10:00:00 |
Practicing Alliance Management, a Biotech Perspective (10:00-10:40) |
Jeremy Ahouse
|
| 10:40:00 |
Intro-Net-Networking Coffee Break and One to One Meetings (10:40-11:20) |
|
| 11:20:00 |
"Building Alliance Flexibility to Enhance Value“: The Enhanze Technology Partnership Between Roche and Halozyme Therapeutics (11:20-1200) |
Louk Pechtold, Michael F. Haller
|
| 12:00:00 |
Networking Luncheon (12:00-13:15) |
|
| 13:15:00 |
Best Practices in Building Successful Biotech-Big Pharma Alliances –Aligning Expectations and Creating Effective Biotech-Big Pharma Communications (13:15-13:55) |
James Philipson
|
| 13:55:00 |
The Biogen Idec Innovation Incubator – A New Model for Industry Partnering with Academia (13:55-14:35) |
Rainer Fuchs
|
| 14:35:00 |
The Novartis / Human Genome Sciences Albuferon Alliance – Key Success Factors in Driving Successful Biotech/Big Pharma Alliances (14:35-15:15) |
Mark Coflin, Marjorie Fischbein
|
| 15:15:00 |
Intro-Net Refreshment and Networking Break (15:15-15:55) |
|
| 15:55:00 |
Becoming a "Partner of Choice" - Roundtable Discussions of What Partner of Choice Really Means and If and How Alliance Management Can Effect It (15:55-17:05) |
Stuart Kliman
|
| 17:05:00 |
Drug Development in India and China: Planning, Implementing and Managing Drug Discovery & Development Activities (17:05-17:45) |
Eric Meyers
|
| 17:45:00 |
Networking Cocktail Reception (17:45-19:00) |
|
| 19:00:00 |
End of Day One |
|
| Tuesday, November 6, 2007 |
| 08:30:00 |
ASAP BioPharma Council Meeting (08:30-09:30) |
Mike Leonetti
|
| 09:30:00 |
The Challenges of Achieving Aligned Decision-making in Pharma/Biotech Collaborations - The ASAP/Humentum BioPharma Council’s Alliance Simulation Project (09:30-10:10) |
Michael Ransom, Mike Epps
|
| 10:10:00 |
Intro-Net-Networking Coffee Break and One to One Meetings (10:10-10:50) |
|
| 10:50:00 |
The Role of Alliance Management in Creating Successful Collaborations at Genentech (10:50-11:30) |
Ashraf Hanna
|
| 11:30:00 |
Partnering with the NCI/NIH (11:30-12:00) |
John Gilly
|
| 12:00:00 |
Lunch on Your Own (12:00-13:30) |
|
| 13:30:00 |
From Good to Great: The Flomax® Alliance – An Alliance Case Study (13:30-14:10) |
Karen Iannella, Jeffrey Shuman
|
| 14:10:00 |
Biotech and Pharma Perspectives on Operating Guidelines for the Effective Management of Alliances (14:10-14:50) |
Xavier Avat, Grace Colon
|
| 14:50:00 |
Intro-Net- Networking Coffee Break and One to One Meetings (14:50-15:30) |
|
| 15:30:00 |
Panel Discussion: Pharma and Biotech Perspectives on Operating Guidelines for Effective Management of Co-Development Alliances An ASAP- CHI (15:30-16:10) |
Jeremy Ahouse, Xavier Avat, Grace Colon
|
| 16:10:00 |
Panel Discussion; Beyond the Financials: Engaging Alliance Partners in Measuring Success (16:10-16:50) |
Lynda McDermott, Ellen McCune
|
| 16:50:00 |
End of ASAP-CHI BIO-Pharma Alliance Summit |
|
How We Rank